Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The source contains a malformed comparison in its low-pressure myocardial-infarction initiation sentence. Do not use that sentence as an executable algorithm; consult current labeling.
Renal method: Creatinine clearance, mL/min Source date: Revision not established in selected sections Retrieved: 2026-09-10
Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding
Distinguish initial dosing from maintenance; confirm formulation, indication, blood pressure, potassium and interacting medicines.
Dialysis evidence: A dialysis-population initial dose is reported; maintenance requires titration
Selected source sections stored locally. Not a complete monograph or independent clinical approval.
Renal guidance and important limits
Limits that apply to these rows
This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.
Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.